Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 4, 2006
Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibitionChristian Brenneis, Thorsten J Maier, Ronald Schmidt, et al.Journal of Lipid Research|August 20, 2008
The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesisSusanne Schiffmann, Jessica Sandner, Ronald Schmidt, et al.Diabetes Care|October 25, 2012
Plasma exposure to insulin glargine and its metabolites M1 and M2 after subcutaneous injection of therapeutic and supratherapeutic doses of glargine in subjects with type 1 diabetesGeremia B Bolli, Annke D Hahn, Ronald Schmidt, et al.Hypertension (Dallas, Tex. : 1979)|February 9, 2005
Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertensionOliver Jung, Ralf P Brandes, In-Hae Kim, et al.Journal of Cellular and Molecular Medicine|April 19, 2008
Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-deficient miceChristian Brenneis, Ovidiu Coste, Ronald Schmidt, et al.Journal of Molecular Medicine (Berlin, Germany)|February 24, 2007
The effects of COX-2 selective and non-selective NSAIDs on the initiation and progression of atherosclerosis in ApoE-/- miceJulia Metzner, Laura Popp, Claudiu Marian, et al.Diabetes Care|October 23, 2012
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetesPaola Lucidi, Francesca Porcellati, Paolo Rossetti, et al.Biochemical Pharmacology|August 12, 2008
Celecoxib inhibits 5-lipoxygenaseThorsten J Maier, Lars Tausch, Michael Hoernig, et al.Circulation|March 19, 2008
Microsomal prostaglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarctionNorbert Degousee, Shafie Fazel, Denis Angoulvant, et al.Pageof 3